“…Anogenital tract HPVs, of which ~40 have been identified, are divided into those which confer a "low risk" (types 6, 11, 42) or a "high risk" (types 16, 18, 31) for cervical cancer Sakai et al, 1996;zur Hausen, 1999zur Hausen, , 2000. Studies performed by Harold Zur Hausen's laboratory provided the first definitive evidence that HPVs were present in genital cancers (Bosch et al, 1991;Durst et al, 1983;Gissmann et al, 1984;Schwarz et al, 1985;zur Hausen, 1999zur Hausen, , 2000zur Hausen et al, 1975zur Hausen et al, , 1981. After more than 20 years of work, HPVs are now recognized as a necessary cause in 95% of invasive cervical cancers worldwide (Walboomers et al, 1999).…”